Market Access/ News/ News CHMP backs bluebird bio’s gene therapy for rare disease ALD Phil Taylor bluebird bio, CALD, CHMP, EU, gene therapy, rare disease, Skysona 0 Comment US biotech bluebird bio has had a challenging time in the last few months, so a recommendation for Share X CHMP backs bluebird bio’s gene therapy for rare disease ALD https://pharmaphorum.com/news/chmp-backs-bluebird-bios-gene-therapy-for-rare-disease-ald/
bluebird bio, CALD, CHMP, EU, gene therapy, rare disease, Skysona
0 Comment
